Welcome to the Healthcare Policy Pop
April 27, 2023

Liver Disease Patients at ICER, Healthcare Congressional Focus

Liver Disease Patients at ICER, Healthcare Congressional Focus

Donna Cryer, CEO of the Global Liver Institute, previews liver disease patient advocates’ testimonies ahead of an ICER meeting on two new treatments; the House Health, Employment, Labor and Pensions Subcommittee holds a hearing titled Reducing...

Donna Cryer, CEO of the Global Liver Institute, previews liver disease patient advocates’ testimonies ahead of an ICER meeting on two new treatments; the House Health, Employment, Labor and Pensions Subcommittee holds a hearing titled Reducing Health Care Costs for Working Americans and Their Families; the House Energy and Commerce Health Subcommittee hosted its own meeting about the importance of addressing unaffordable costs in healthcare; and correspondent Kathi Luis lives in Michigan’s 9th district and sees how Copay Accumulator programs are hurting patients.

Global Liver Institute Webpage

CNBC News Article: FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

Patients Rising Webpage: Patients Rising Stories

Donna Cryer

CEO, Global Liver Institute.

CEO, Global Liver Institute.

Kathi Luis

Patient Advocate, MI-09

Patient advocate with the Amyloidosis Foundation.